JAFL
RLAY icon

Jay A. Fishman Ltd’s Relay Therapeutics RLAY Stock Holding History

Jay A. Fishman Ltd’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,000
Closed -$84.1K – 94
2023
Q3 		$84.1K Hold
10,000
– – 0.01% 95
2023
Q2 		$126K Hold
10,000
– – 0.02% 96
2023
Q1 		$165K Hold
10,000
– – 0.02% 90
2022
Q4 		$149K Buy
+10,000
New +$191K 0.02% 93

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Jay A. Fishman Ltd's RLAY Position: Q4 2023 in Review

Jay A. Fishman Ltd sold out of Relay Therapeutics (RLAY) in Q4 2023, closing a stake of 10,000 shares — an estimated $84.1K sold.

Jay A. Fishman Ltd first reported a position in RLAY in Q4 2022 and held it in 4 quarters. The position peaked at $165K in Q1 2023. 177 funds tracked by Wall St. Rank hold RLAY as of Q4 2023.

  • Jay A. Fishman Ltd reported no remaining Relay Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 10,000 Relay Therapeutics shares in Q4 2023, an estimated $84.1K.
  • Jay A. Fishman Ltd first reported a position in Relay Therapeutics in Q4 2022 and held it in 4 quarters.
  • Jay A. Fishman Ltd's Relay Therapeutics position peaked at $165K in Q1 2023.
  • 177 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2023.

Based on Jay A. Fishman Ltd's 13F filing for Q4 2023, filed 24 Jan 2024.